Bioventus (BVS) Net Margin (2020 - 2026)
Bioventus' (BVS) quarterly Net Margin came in at 23.63% in Q2 2026, up 1735.0% on a YoY basis from 1.29% in Q2 2025, and up 691.04% quarter-over-quarter from 2.99% in Q1 2026.
Powered by 
Analysis
Bioventus (BVS) Net Margin (2020 - 2026) Analysis & Trends
Bioventus (BVS) has reported Net Margin for 7 consecutive years, with 23.63% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 1735.0% year-over-year to 23.63%; the trailing twelve-month figure through Jun 2026 stood at 10.57% (up 1065.0% YoY), and the FY2025 full-year result was 4.8%, up 1301.0% from the prior year.
- Net Margin climbed to 23.63% in Q2 2026 per BVS's latest filing, from 2.99% in the prior quarter.
- Across five years, Net Margin topped out at 23.63% in Q2 2026 and bottomed at 146.52% in Q2 2023.
- Historically, Net Margin has averaged 17.68% across 5 years, with a median of 4.57% in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Margin plunged 13390 bps in 2023, then surged 14159 bps in 2024.
- Over 5 years, Net Margin stood at 35.66% in 2022, then surged by 84 bps to 5.65% in 2023, then jumped by 93 bps to 0.39% in 2024, then jumped by 2895 bps to 10.97% in 2025, then soared by 115 bps to 23.63% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 23.63%, 2.99%, and 10.97% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.47% |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | 23.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 23.63% |
| Mar 28, 2026 | 2.99% |
| Dec 31, 2025 | 10.97% |
| Sep 27, 2025 | 2.89% |
| Jun 28, 2025 | 6.28% |
| Mar 29, 2025 | -2.68% |
| Dec 31, 2024 | -0.39% |
| Sep 28, 2024 | -4.21% |
| Jun 29, 2024 | -22.63% |
| Mar 30, 2024 | -4.93% |
| Dec 31, 2023 | -5.65% |
| Sep 30, 2023 | -7.28% |
| Jul 1, 2023 | -3.45% |
| Apr 1, 2023 | -146.52% |
| Dec 31, 2022 | -35.66% |
| Oct 1, 2022 | -113.24% |
| Jul 2, 2022 | -5.71% |
| Apr 2, 2022 | -12.62% |
| Dec 31, 2021 | -0.02% |
| Oct 2, 2021 | -2.08% |